Gregory D. Jordan serves as Executive at KING PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Gregory D. Jordan has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 31, 2011 involved transacting 41,679 shares valued at $0.
Gregory D. Jordan currently holds 57,880 shares of KING PHARMACEUTICALS INC (KG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory D. Jordan has been a net neutral trader of KG stock. They have purchased $0 and sold $0 worth of shares.
Gregory D. Jordan's most recent insider trade was on Jan 31, 2011, when they sold 41,679 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.95 |
| Discretionary |
| May 15, 2009 | KG | $0 | Award | 15,358 | $N/A | Discretionary |
| May 15, 2008 | KG | $0 | Award | 13,527 | $N/A | Discretionary |
| Apr 30, 2007 | KG | $0 | Award | 5,867 | $N/A | Discretionary |
| Oct 2, 2006 | KG | $0 | Award | 1,177 | $N/A | Discretionary |
| Apr 28, 2006 | KG | $0 | Award | 5,750 | $N/A | Discretionary |